# Adalimumab-psoriasis and Small Bowel Lesions

> **NCT01556672** · PHASE4 · COMPLETED · sponsor: **Innovaderm Research Inc.** · enrollment: 100 (actual)

## Conditions studied

- Plaque Psoriasis
- Crohn's Disease

## Interventions

- **DRUG:** Adalimumab
- **DEVICE:** Capsule endoscopy

## Key facts

- **NCT ID:** NCT01556672
- **Lead sponsor:** Innovaderm Research Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2016-01
- **Final completion:** 2016-04
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01556672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01556672, "Adalimumab-psoriasis and Small Bowel Lesions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01556672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*